Search | SPORTIVO Network

rishika_2003 added blog Health
2026-03-13 10:16:02

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Comments 0 Shares 247 Views 0 Reviews

Please log in to like, share and comment!
naznins407 added blog Health
2026-03-04 08:38:25

Market Outlook 2025–2031: Future of Sarcoma Drug Development
Orphan drug designation is supporting market expansion.Regulatory incentives encourage rare cancer drug development.Faster approvals enhance product commercialization opportunities The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...

1

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
naznins407 added blog Health
2026-03-04 13:05:45

Rising Oncology Advances Boost Bladder Cancer Market Value
Precision medicine is revolutionizing bladder cancer management strategies.Personalized treatment plans based on genetic profiling improve effectiveness.This trend is expanding opportunities within both therapeutics and diagnostics segments. The Bladder Cancer Therapeutics and Diagnostics Market is projected to register a robust CAGR of 10.2% from 2025 to 2031, with market size expanding...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
naznins407 added blog Health
2026-03-05 05:15:07

Sarcoma Drugs Market Forecast 2025–2031: Opportunities in Rare Cancer Therapies
The rising demand for innovative cancer therapies is fueling the Sarcoma Drugs Market globally. Researchers are focusing on immunotherapy and combination therapies to improve treatment effectiveness. Such developments are strengthening the oncology drug pipeline. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from US$ XX million...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!